ROBERT EDWARD DEMPSKI
Pharmacy in Dresher, PA
License number
Pennsylvania RP022679L
Category
Pharmacy
Type
Pharmacist
Address
Address
Dresher, PA 19025
Personal information
See more information about ROBERT EDWARD DEMPSKI at radaris.comName
Address
Phone
1629 Arran Way, Dresher, PA 19025
1629 Arran Way, Dresher, PA 19025
Ambler, PA
1629 Arran, Pocono Pines, PA 19025
Pocono Lake, PA
Professional information
See more information about ROBERT EDWARD DEMPSKI at trustoria.com
Controlled Release Combination Of Carbidopa/Levodopa
Controlled Release Combination Of Carbidopa/Levodopa
US Patent:
4983400, Jan 8, 1991
Filed:
Dec 1, 1989
Appl. No.:
7/444222
Inventors:
Robert E. Dempski - Dresher PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 922, A61K 926, A61K 3178
US Classification:
424469
Abstract:
A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levodopa combination presently employed.
Sustained Release Indomethacin
Sustained Release Indomethacin
US Patent:
4173626, Nov 6, 1979
Filed:
Dec 11, 1978
Appl. No.:
5/968608
Inventors:
Robert E. Dempski - Dresher PA
Gunvant N. Mehta - Lansdale PA
Joseph C. Saboe - Norristown PA
Gunvant N. Mehta - Lansdale PA
Joseph C. Saboe - Norristown PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 922, A61K 948
US Classification:
424 19
Abstract:
A sustained release indomethacin pharmaceutical product is provided that utilizes a pellet formulation encapsulated in a hard gelatin capsule. A portion of the pellets is uncoated for immediate and rapid release of indomethacin for elevating the plasma level. The remainder of the pellets are coated with a polymer to sustain the plasma level. The uncoated and coated pellets may be mixed with non-medicated pellets as a capsule filler.
Controlled Release Combination Of Carbidopa/Levodopa
Controlled Release Combination Of Carbidopa/Levodopa
US Patent:
4832957, May 23, 1989
Filed:
Jul 25, 1988
Appl. No.:
7/223861
Inventors:
Robert E. Dempski - Dresher PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 920, A61K 922, A61K 926
US Classification:
424469
Abstract:
A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levodopa combinations presently employed.
Controlled Release Combination Of Carbidopa/Levodopa
Controlled Release Combination Of Carbidopa/Levodopa
US Patent:
4900755, Feb 13, 1990
Filed:
Feb 24, 1989
Appl. No.:
7/315057
Inventors:
Robert E. Dempski - Dresher PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA
Edward C. Scholtz - King of Prussia PA
Donald W. Nibbelink - Lansdale PA
Scott A. Reines - New Hope PA
Assignee:
Merck & Co. - Rahway NJ
International Classification:
A61K 920, A61K 922, A61K 926
US Classification:
424469
Abstract:
A matrix or monolithic drug delivery system for the controlled release of carbidopa and levodopa consists of the two drugs uniformly dispersed in a polymer vehicle at a concentration that is greater than the solubility of either drug in the polymer. Treatment of parkinsonism with the controlled release formulation provides several advantages over treatment with the standard carbidopa/levidopa combinations presently employed.
Methyldopa Composition
Methyldopa Composition
US Patent:
4404193, Sep 13, 1983
Filed:
Oct 9, 1981
Appl. No.:
6/309956
Inventors:
Robert E. Dempski - Dresher PA
Joseph L. O'Neill - Lansdale PA
Joseph L. O'Neill - Lansdale PA
Assignee:
Merck & Co., Inc. - Rahway NJ
International Classification:
A61K 31195, A61K 31715
US Classification:
424176
Abstract:
An aqueous suspension containing methyldopa and sucrose is disclosed. This composition is an oral dosage form for treating hypertension that is bioavailable.